Wait Time and Patient Satisfaction—Improving Outcomes Can Be as Easy as Child’s Play

VBCC - March 2013, Volume 4, No 3 - AVBCC 2013 3rd Annual Conference Abstracts
Julia Whiteker
Ann Bredensteiner

Background: Breast Care at IU Health North Hospital is a multidisciplinary clinic comprised of breast surgeons, medical and radiation oncologists, plastic surgeons and geneticists. It has consistently achieved excellent patient satisfaction scores; however, one area needing improvement was in office wait time. Patient responses to the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) survey question “During your most recent visit, did you see this provider within 15 minutes of your appointment time?” had been ranked in the 3rd, 38th and 63rd percentile consecutively for the first three quarters (Q) of 2012 by the National Research Corporation (NRC) Picker data.

Objective: To improve patient satisfaction on wait time.

Methods: Wait time for the first patient of each clinic session (morning/afternoon) for each provider was measured each day. Team members (providers, registration staff, medical assistants and nurses) were rewarded with incentives if the patient was seen within 15 minutes of their scheduled appointment time regardless of patient arrival time. On time starts were tracked in full view of the team. Rewards started October 1, 2012, with a communication to all providers and staff in our program. Total cost of implementation was $50 per quarter for incentives.

Results: One week prior to the intervention, baseline wait time was measured. With an average wait time of 17 minutes, only 50% were seen on time. After initiation of the intervention, Q4 of 2012, 96 first starts were measured. The average wait time for all first starts after intervention was 9 minutes and 77% of the patients saw her provider within 15 minutes of her appointment time. In 14 of the 23 late start cases, the patient arrived more than 10 minutes after her appointment time. Patient satisfaction on the CGCAHPS recent wait time question was in the 100th percentile for Q4 2012.

Conclusions: Seeing a change on CGCAHPS recent wait time from the 63rd percentile in Q3 to the 100th percentile in Q4 represents an encouraging trend for this intervention. This project is ongoing to determine if this trend will continue. Patients do arrive late which in turn causes the clinic to run late. However, we realized the timeliness of the patients’ arrival was a much smaller factor than originally anticipated. Accountability played a key role. By setting our goal at 15 minutes, there was no room for excuses. It was much easier to address the problem when all team members realized their role in on time starts, not just the providers. This intervention also anecdotally improved team morale and a sense of efficiency.

Related Items
Perspectives of Quality Care in Cancer Treatment: A Review of the Literature
Lisa M. Hess, PhD, Gerhardt Pohl, PhD
VBCC - March 2013, Volume 4, No 3 published on April 1, 2013 in AVBCC 2013 3rd Annual Conference Abstracts
Is Oral Electrolyte Replacement More Effective than IV Replacement in the Oncology Population?
Rebecca Martin, BSN, RN, OCN, Joanne Growney, RN, MA, ANP-BC
VBCC - March 2013, Volume 4, No 3 published on April 1, 2013 in AVBCC 2013 3rd Annual Conference Abstracts
Cost Considerations for New Oral Therapies for Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) Previously
Lorie A. Ellis, Zoe Clancy, R. Scott McKenzie, Mekre’ Senbetta
VBCC - March 2013, Volume 4, No 3 published on April 1, 2013 in AVBCC 2013 3rd Annual Conference Abstracts
Cost Analysis of Bortezomib Retreatment Compared with Switching to Carfilzomib in Patients with Relapsed Multiple Myeloma Previously Treated with Bortezomib
Kevin B. Knopf, MD, MPH, Marie-Hélène Lafeuille, MA, Jonathan Gravel, MS, Patrick Lefebvre, MA, Liviu Niculescu, MD, Abbie Ba-Mancini, MBA, Esprit Ma, MPH, Mei Sheng Duh, MPH, ScD
VBCC - March 2013, Volume 4, No 3 published on April 1, 2013 in AVBCC 2013 3rd Annual Conference Abstracts
Imatinib Can Still Be Used as 1st-Line for Treating Chronic Myelogenous Leukemia
Wesley Wong, PhD
VBCC - March 2013, Volume 4, No 3 published on April 1, 2013 in AVBCC 2013 3rd Annual Conference Abstracts
Say Ahh! Making Sense of Oral Assessments for Mucositis
Joanne Growney, MA, RN, ANP-BC, OCN, Rebecca Martin, BSN, RN, OCN, Phyllis McKiernan, RN, MSN, APN-BC, Joan Collela, RN, DNP, APN-BC, NP-C, Claudia Douglas, RN, MA, CNN, APN-C
VBCC - March 2013, Volume 4, No 3 published on April 1, 2013 in AVBCC 2013 3rd Annual Conference Abstracts
Impact of Granulocyte Colony-Stimulating Factor and Treatment Modification on Eribulin Mesylate Therapy in Metastatic Breast Cancer Patients with Neutropenia
Gluck S, Yardley D, Belk K, Craver C, Cox D, Faria C, University of Miami, Leonard M. Miller School of Medicine, Miami, FL; Tennessee Oncology, PLLC, Nashville, TN; MedAssets, Inc., Charlotte, NC; Eisai Inc., Woodcliff Lake, NJ
VBCC - March 2013, Volume 4, No 3 published on April 1, 2013 in AVBCC 2013 3rd Annual Conference Abstracts
Impact of Treatment Modification on Treatment Duration in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate
VBCC - March 2013, Volume 4, No 3 published on April 1, 2013 in AVBCC 2013 3rd Annual Conference Abstracts
An Assessment of Racial Differences in Toxicities and Supportive Care in Patients with Metastatic Breast Cancer (MBC)
George Dranitsaris, Nancy Beegle, Traci Kalberer, Zhixiao Wang, Claudio Faria, Sibel Blau
VBCC - March 2013, Volume 4, No 3 published on April 1, 2013 in AVBCC 2013 3rd Annual Conference Abstracts
Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients Receiving 5-HT3-RA Therapy throughout Chemotherapy Cycles
Faria C, Nagl N, Powers A. Eisai, Inc. 100 Tice Blvd. Woodcliff Lake, NJ 07667
VBCC - March 2013, Volume 4, No 3 published on April 1, 2013 in AVBCC 2013 3rd Annual Conference Abstracts
Last modified: May 28, 2014
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology